These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20659164)

  • 21. Role of the
    G C B; Sahukhal GS; Elasri MO
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307991
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
    Shonekan D; Mildvan D; Handwerger S
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1570-2. PubMed ID: 1324649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against gram-positive clinical isolates from cancer patients.
    Rolston KV; Dholakia N; Ho DH; LeBlanc B; Dvorak T; Streeter H
    J Antimicrob Chemother; 1996 Aug; 38(2):265-9. PubMed ID: 8877541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.
    Lawrence T; Rotstein C; Beam TR; Gorzynski EA; Amsterdam D
    Antimicrob Agents Chemother; 1993 Apr; 37(4):896-900. PubMed ID: 8494388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy.
    Sieradzki K; Leski T; Dick J; Borio L; Tomasz A
    J Clin Microbiol; 2003 Apr; 41(4):1687-93. PubMed ID: 12682161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens.
    Severina E; Severin A; Tomasz A
    J Antimicrob Chemother; 1998 Mar; 41(3):341-7. PubMed ID: 9578160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS.
    Berscheid A; François P; Strittmatter A; Gottschalk G; Schrenzel J; Sass P; Bierbaum G
    J Antimicrob Chemother; 2014 Dec; 69(12):3190-8. PubMed ID: 25103491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin.
    Cudic P; Behenna DC; Kranz JK; Kruger RG; Wand AJ; Veklich YI; Weisel JW; McCafferty DG
    Chem Biol; 2002 Aug; 9(8):897-906. PubMed ID: 12204689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
    Ghahremani M; Jazani NH; Sharifi Y
    J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible antibiotic tolerance induced in Staphylococcus aureus by concurrent drug exposure.
    Haaber J; Friberg C; McCreary M; Lin R; Cohen SN; Ingmer H
    mBio; 2015 Jan; 6(1):. PubMed ID: 25587013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate.
    Boyle-Vavra S; Carey RB; Daum RS
    J Antimicrob Chemother; 2001 Nov; 48(5):617-25. PubMed ID: 11679550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms.
    Collins LA; Eliopoulos GM; Wennersten CB; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1364-6. PubMed ID: 8328787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curing bacteria of antibiotic resistance: reverse antibiotics, a novel class of antibiotics in nature.
    Hiramatsu K; Igarashi M; Morimoto Y; Baba T; Umekita M; Akamatsu Y
    Int J Antimicrob Agents; 2012 Jun; 39(6):478-85. PubMed ID: 22534508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.
    Hussain FM; Boyle-Vavra S; Shete PB; Daum RS
    J Infect Dis; 2002 Sep; 186(5):661-7. PubMed ID: 12195353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
    Katayama Y; Sekine M; Hishinuma T; Aiba Y; Hiramatsu K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3730-42. PubMed ID: 27067329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
    Sakoulas G; Alder J; Thauvin-Eliopoulos C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1581-5. PubMed ID: 16569891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function.
    Sakoulas G; Eliopoulos GM; Fowler VG; Moellering RC; Novick RP; Lucindo N; Yeaman MR; Bayer AS
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2687-92. PubMed ID: 15980337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobial.
    O'Hare MD; Ghosh G; Felmingham D; Grüneberg RN
    J Antimicrob Chemother; 1990 Feb; 25(2):217-20. PubMed ID: 2139436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methicillin-resistant and vancomycin-intermediate Staphylococcus aureus colonizing patients and intensive care unit environment: virulence profile and genetic variability.
    Veloso JO; Lamaro-Cardoso J; Neves LS; Borges LFA; Pires CH; Lamaro L; Guerreiro TC; Ferreira EMA; André MCP
    APMIS; 2019 Nov; 127(11):717-726. PubMed ID: 31407405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.